A rapidly adaptable biomaterial vaccine for SARS-CoV-2
F. Langellotto, B. T. Seiler, J. Yu…·D. J. Mooney
This study develops a biomaterial vaccine using mesoporous silica rods to deliver SARS-CoV-2 antigens and adjuvants, showing rapid antibody responses and neutralizing activity.